Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
flourishing-businesses-do-not-loose-money-for-10-years-plus
likewise accomplished business leaders do not find themselves on the wrong side of multiple federal agencies
as well frugal/accomplished investors review core fundamentals
tsunami-very-very-very-strong-buy is ok though?
Before investing for long term results evaluate SEC past/present filings:
https://www.sec.gov/alj/aljorders/2016/ap-3761.pdf
....motion is DENIED AS MOOT
....request is therefore DENIED
Seems aligned with previous legalese being applied:
Pertinent keywords/statements as stipulated by the SEC
--> http://www.sec.gov/litigation/admin/2016/33-10036.pdf
....inaccurate public disclosure
....unlawful distribution of securities
....falsely recognizing revenue
....overstated BIELs revenue by $366,000, or 47%.
....engaged in an illegal distribution of unrestricted securities
....unregistered transactions at a discount
....orchestrated the illegal distribution.
....half of the proceeds .....was retained by the entities
....offerings were not registered with the Commission.
....constitutes improper professional conduct.
https://www.sec.gov/litigation/complaints/2011/comp21813.pdf
....simply misappropriated the money they raised from investors...
....took steps to prop up .... stock price by manipulating trading in ..... stock.
....personally placed at least two of these matched orders....
....coordinated the timing and the prices of the bids....
....place buy offers at the same time that others placed sell offers....
Ever-heard-the-term-"Shark", well sharks don't broadcast they are running a scam and quite often verify difficult to legally prove such. That's the sharks intent, to operate between the grey lines of fact & fiction, however that does not infer that aspects of what the shark is selling is not heavily weighted towards the scam arena.
Nearly-$5M-allegedly-bilked-from-investors-and-TOXIC-Dilution-continues
Per SEC Filing --> https://www.sec.gov/litigation/apdocuments/3-17104-event-25.pdf
Cheat sheet for reference:
https://www.sec.gov/alj/aljorders/2016/ap-3761.pdf
....motion is DENIED AS MOOT
....request is therefore DENIED
Seems aligned with previous legalese being applied:
Pertinent keywords/statements as stipulated by the SEC
--> http://www.sec.gov/litigation/admin/2016/33-10036.pdf
....inaccurate public disclosure
....unlawful distribution of securities
....falsely recognizing revenue
....overstated BIELs revenue by $366,000, or 47%.
....engaged in an illegal distribution of unrestricted securities
....unregistered transactions at a discount
....orchestrated the illegal distribution.
....half of the proceeds .....was retained by the entities
....offerings were not registered with the Commission.
....constitutes improper professional conduct.
https://www.sec.gov/litigation/complaints/2011/comp21813.pdf
....simply misappropriated the money they raised from investors...
....took steps to prop up .... stock price by manipulating trading in ..... stock.
....personally placed at least two of these matched orders....
....coordinated the timing and the prices of the bids....
....place buy offers at the same time that others placed sell offers....
February-5th-the-SEC-took-a-small-action-against-the-Company
Can you say glass is 1/2 full?
Before investing for long term results evaluate SEC past/present filings:
https://www.sec.gov/alj/aljorders/2016/ap-3761.pdf
....motion is DENIED AS MOOT
....request is therefore DENIED
Seems aligned with previous legalese being applied:
Pertinent keywords/statements as stipulated by the SEC
--> http://www.sec.gov/litigation/admin/2016/33-10036.pdf
....inaccurate public disclosure
....unlawful distribution of securities
....falsely recognizing revenue
....overstated BIELs revenue by $366,000, or 47%.
....engaged in an illegal distribution of unrestricted securities
....unregistered transactions at a discount
....orchestrated the illegal distribution.
....half of the proceeds .....was retained by the entities
....offerings were not registered with the Commission.
....constitutes improper professional conduct.
https://www.sec.gov/litigation/complaints/2011/comp21813.pdf
....simply misappropriated the money they raised from investors...
....took steps to prop up .... stock price by manipulating trading in ..... stock.
....personally placed at least two of these matched orders....
....coordinated the timing and the prices of the bids....
....place buy offers at the same time that others placed sell offers....
Recent-pps-haircut-nearly-30-40%,not-quite-what-rational-investors-term-calm
Visualizing-investment-being-flushed-down-drain
Be-patient-will-happen-b4-FDA-or-profitability
Likewise,Courtesy-the-SEC
Before investing for long term results evaluate SEC past/present filings:
https://www.sec.gov/alj/aljorders/2016/ap-3761.pdf
....motion is DENIED AS MOOT
....request is therefore DENIED
Seems aligned with previous legalese being applied:
Pertinent keywords/statements as stipulated by the SEC
--> http://www.sec.gov/litigation/admin/2016/33-10036.pdf
....inaccurate public disclosure
....unlawful distribution of securities
....falsely recognizing revenue
....overstated BIELs revenue by $366,000, or 47%.
....engaged in an illegal distribution of unrestricted securities
....unregistered transactions at a discount
....orchestrated the illegal distribution.
....half of the proceeds .....was retained by the entities
....offerings were not registered with the Commission.
....constitutes improper professional conduct.
https://www.sec.gov/litigation/complaints/2011/comp21813.pdf
....simply misappropriated the money they raised from investors...
....took steps to prop up .... stock price by manipulating trading in ..... stock.
....personally placed at least two of these matched orders....
....coordinated the timing and the prices of the bids....
....place buy offers at the same time that others placed sell offers....
factually-False-->the company has not been diluting
Read the companies latest financial reporting
Bottom-Line?
End-of-day-we-have-a-0.000#-PPS,15B-AS,11B-OS.....
The rest is all fodder
Braun-does-not-buy-company-shares;)
Assumption is Braun purchases product below cost and contributes to why company fails to show net profit
As long a Braun can ensure limited brand liability and net profit on channel sales then adds to companies overall bottom line.
What-is-working-is-TOXIC-DILUTION-leveraging-uninformed-invetsors
Latest financials released absolutely refute any claims that TOXIC DILUTION has been reduced and or discontinued.
There-is-however-substantial-SEC-filed-information-that-refutes-this-claim-as-"INCORRECT"
--> the family is fully invested and committed to making this work
Before investing for long term results evaluate SEC past/present filings:
https://www.sec.gov/alj/aljorders/2016/ap-3761.pdf
....motion is DENIED AS MOOT
....request is therefore DENIED
Seems aligned with previous legalese being applied:
Pertinent keywords/statements as stipulated by the SEC
--> http://www.sec.gov/litigation/admin/2016/33-10036.pdf
....inaccurate public disclosure
....unlawful distribution of securities
....falsely recognizing revenue
....overstated BIELs revenue by $366,000, or 47%.
....engaged in an illegal distribution of unrestricted securities
....unregistered transactions at a discount
....orchestrated the illegal distribution.
....half of the proceeds .....was retained by the entities
....offerings were not registered with the Commission.
....constitutes improper professional conduct.
https://www.sec.gov/litigation/complaints/2011/comp21813.pdf
....simply misappropriated the money they raised from investors...
....took steps to prop up .... stock price by manipulating trading in ..... stock.
....personally placed at least two of these matched orders....
....coordinated the timing and the prices of the bids....
....place buy offers at the same time that others placed sell offers....
There-is-not-any-company-released-information-that-supports-this-claim
--> the family is fully invested and committed to making this work
Super Mega Strong Odor of rotten Quarter, no indication any change for any subsequent quarters.
Beginning to gain more confidence that overhead will recapture anything that would potentially contribute to a profitable balance sheet.
Blinded-by-$$$$-Smart-Relief-followed-process-and-is-US-OTC
If ever Acti-Patch were to see the distribution volumes and availability that a product like Smart-Relief has there would be Ambulance Chasers all over it, that's just the way the eco-system works.
Given Acti-Patch has not achieved the level of FDA approvals necessary to effectively compare, yes the whole topic is speculative.
Let's pretend for a moment you had no monetary interest in Acti-patch, would you still be shouting from the top of the mountain as you are? What's your honest motivation, please do not try and convey you are looking for the best interest of the Opioid addicted American population.
Just remember, any American who really wants Acti-Patch can easily acquire it via pet product avenues. If the demand was there it would be happening.
The whole FDA topic is about capitalizing on PINK sheet speculation on FDA approval being announced, the benefit to Americans is in all honesty a secondary aspect.
Your-analysis-while-viable-using-linear-extrapolation
The challenge is the company does not provide clarity as to operational costs and thus we have no means to know the ratio or trends/linearity that would correlate to your typical extrapolations.
The ratio of cost/expenses/sales and subsequent net-profit does not seem linear which is what your extrapolations are based on.
BS-you-have-no-idea-how-much-money-is-being-allocated-to-executive-salaries
Nothing-the-company-released-suggests-they-will-achieve-net-profit at any sales volume. There is no way to know the relationship of why even as volumes increase they continue to loose money on every item sold.
Time-table-skewed-by-company-PR
The timelines for when,what,why FDA has instructed BIEL is unknown as the company has on multiple occasions now demonstrated a propensity to not notify "HIDE" investors/public from the details as to what,when,why related to FDA telling them "You aint doing it right!"
If-biel-leadership-played-by-the-rules then institutional investment capital would have surfaced, subsequently captains who understand how to navigate the FDA process would have steered the ship, unloaded the cargo and then headed back home with a containers full of cash.
Reasonably confident smart-relief 1st assessed a build vs buy strategy and opted for the path that has allowed for their product to be available to the US market for years now.
At the end of the day the results speak for themselves, we have a failure to execute by Biel leadership.
Gotta admit though, the TOXIC Dilution campaign has funded years of slow to sluggish progress.
Kinda-like-saying-stock-market-is-rigged
Irrelevant if you don't play by their rules you loose.
Biel plain and simple needs to play within rules instead of trying to avert the establishment.
Else, be satisfied from what can be accomplished in other markets.
Ok-its-all-the-FDA-&-SEC-problem-BIEL-is-completely-not-responsible
Both FDA & SEC seem to think BIEL is not following proper business practices.
Pretty confident some are jaded by the expectation of being entitled to a ROI by investing in a PINK and the fact that reward is not forth coming looking for someone to blame.
Focus-on-key-words-->"FDA believes the 510(k) route is inappropriate"
This is directly in opposition to the predicate/510k strategy.
Difficult to read between the lines of the PR's from this company.
However, with the help of SEC scrutiny we can hope for a bit less propensity to release PR's that induce speculative investing.
This information was likely known many months ago and only now are they choosing to release a bipolar PR.
"FDA believes the 510(k) route is inappropriate"
Another example of company not understanding process and not consulting with appropriate expertise and yet inducing additional delays.
http://www.prnewswire.com/news-releases/bioelectronics-responds-to-us-fdas-comments-on-its-market-clearance-application-300265743.html
Do-not-have-to-be-"Day-Trader"-to-make-$$-on-news
Definitely-alternate-reality-please-review-PPS-and-FDA-status
How can we suggest SUPER DUPER MEGA STRONG BUY when losses exceeding 40% in few hours?
Not 1st occurrence of 50% swings in the history of this stock.
Reiterate, buy/sell on news to see ROI
Do not long hold on speculation
Yeah-sentiment-"reality"-of-"SUPER_MEGA_STRONG_BUY-is-->"S h a d y"
Company could/should have shared insights to lack of FDA progress months ago.
Trade on the news to realize ROI, discourage long holdings, all, 100% of longs in this stock have lost money.
Entities-used-monies-for-what-purposes?
Approximately half of the proceeds of these sales were then “loaned”
to BIEL and the other half was retained by the entities.
Doh!,if-that-were-FACTually-accurate-then-predicate-device-would-be-mute-point
--> Again, what matters is the current filing. Nothing else matters to FDA
FDA-must-disagree-as-clearance-does-not-appear-within-reach
Past filings from company are why FDA did not act.
If you read through the reclassification documents, very little is provided from Biel representatives.
Suggesting the product and technology has merits, but this specific company has history that makes it very difficult to have confidence to the degree being suggested should have
Getta-clue-the-CEO-has-not-used-majority-of-investor-capital-to-move-company-forward Yeah, that may be under the guise of working for the company, but the fact is for every dollar of investor money derived from TOXIC dilution campaign, according to SEC filings 50% has been pocketed and not used to move the company forward.
If the company was legitimate we would have seen conglomerates scoop up the technology and company. The big boys would have made the family an offer they could not refuse, literally and connotations implied intentionally.
Time-will-tell,history-is-not-on-the-long-investors-side for this stock.
Unless you are a trader, this stock has not provided a ROI to date, and there is significant history behind this stock. Significant more history then would be expected from a pink.
Gotta-be-able-to-differentiate-fact-from-fiction/speculation
o Product has potential
o Company bringing product to market has some baggage
The totality of well documented facts are where the risk/reward lays.
FACT->Family-Orchestrated-Funding-Dilution-paradigms-utilized
As mentioned in multiple SEC filings spanning multiple family members and likely "Shell" companies that seem to have an affinity for shinnanigans
Before investing for long term results evaluate SEC past/present filings:
https://www.sec.gov/alj/aljorders/2016/ap-3761.pdf
....motion is DENIED AS MOOT
....request is therefore DENIED
Seems aligned with previous legalese being applied:
Pertinent keywords/statements as stipulated by the SEC
--> http://www.sec.gov/litigation/admin/2016/33-10036.pdf
....inaccurate public disclosure
....unlawful distribution of securities
....falsely recognizing revenue
....overstated BIELs revenue by $366,000, or 47%.
....engaged in an illegal distribution of unrestricted securities
....unregistered transactions at a discount
....orchestrated the illegal distribution.
....half of the proceeds .....was retained by the entities
....offerings were not registered with the Commission.
....constitutes improper professional conduct.
https://www.sec.gov/litigation/complaints/2011/comp21813.pdf
....simply misappropriated the money they raised from investors...
....took steps to prop up .... stock price by manipulating trading in ..... stock.
....personally placed at least two of these matched orders....
....coordinated the timing and the prices of the bids....
....place buy offers at the same time that others placed sell offers....
Sorry-to-dissapoint-its-just-a-data-point that reflects on the perceptions of potentially ill-motivated individual, difficult to know for sure.
If the product takes off, there will be ambulance chasers for sure that the company will need to derive defenses for.
Amazon-reviews-->"It didn't work for me at all"
www.amazon.com/gp/customer-reviews/R3995NHL085RP/ref=cm_cr_arp_d_rvw_ttl?ie=UTF8&ASIN=B00RLLN3IM
IMPORTANT: If you read the full text of the 5 Star reviews, you will find that some were admittedly written by stockholders in the maker's company(they say so in the review). I'm not saying they are false, but I'm not sure a stockholder can be objective about a product from a company in which they own stock. When I get NO positive results, and there are reviews claiming miracles... hmmmmm....
I really wanted this product to work for me, but it didn't. Also, There was no velcro on it to keep it on. I wound up wrapping it around me and then stapling it. You'll see that in the video. You'll also see how to take the unit apart so that you can replace the battery if you want to.
I wore it non-stop for 30 days. I only took it off to shower, and I really didn't notice any difference. I don't plan to try it again, but if I do, I'll let you know, but don't hold your breath. (Contrary to the instructions, the battery IS replaceable if you have a little ingenuity or a 12 year old child around.)
CAUTION #1 --- DECEPTIVE MARKETING/ADVERTISING: The claim of FDA approval of this product isn't for anything you or I are buying this for, nor anything which is proclaimed on their packaging such as "For Back Pain", or "For Heel Pain", etc. See more in the video
CAUTION #2 --- NEGATIVE REVIEWERS ARE ATTACKED: While their investors, or their employees are writing and posting 5 Star reviews so that they can sell more units, people who wrote negative reviews are attacked or made fun of. (Read "comments" on any negative review for examples.) A good product doesn't need to attack people who write negative reviews, they can rely on the REAL reviews to demonstrate the product is good on its own merits.